Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00000882
What this trial is testing

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT00001968
What this trial is testing

Once-Daily Drug Regimen for HIV-Infected Patients

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT00000991
What this trial is testing

Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 600
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00002452
What this trial is testing

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Large-scale testing (Phase 3)Study completedNCT00005758
What this trial is testing

Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 472
Large-scale testing (Phase 3)Study completedNCT00021671
What this trial is testing

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,720
Testing effectiveness (Phase 2)Study completedNCT00001087
What this trial is testing

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00006291
What this trial is testing

Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00001108
What this trial is testing

The Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Testing effectiveness (Phase 2)Study completedNCT00004985
What this trial is testing

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 75
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Testing effectiveness (Phase 2)Temporarily pausedNCT00002424
What this trial is testing

Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 186
Testing effectiveness (Phase 2)WithdrawnNCT00021762
What this trial is testing

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00000635
What this trial is testing

Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine

Who this might be right for
Herpes SimplexHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00001068
What this trial is testing

Disease Progression and Anti-HIV Treatments

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 210
Not applicableStudy completedNCT00002201
What this trial is testing

Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
Abbott
Early research (Phase 1)Study completedNCT00002372
What this trial is testing

141W94 in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation